Patent · US Active

P2X7R antagonists and their use

US7919503B2 · kind B2 · utility

3Cited by

0References

12Claims

0Family size

Assignee

Affectis Pharmaceuticals AG · DE

Inventor

Michael Boes · Lörrach, DE

Key dates

Filing date	Apr 12, 2010
Grant date	Apr 5, 2011
Priority date	—
Expiry date	Apr 12, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.